Understanding How Air Pollution Affects Eye Health and Infections
Airborne Particulates, Corneal Oxidative Stress and Infection
This project explores how tiny airborne particles cause eye inflammation and make infections worse, and if a special antioxidant can help.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project ID | NIH-11131147 on NIH RePORTER |
What this research studies
Tiny airborne particles, known as PM10, are a common pollutant linked to eye problems like keratitis and dry eye. We don't yet fully understand how these particles harm the eye or make it more vulnerable to infections. This work aims to discover if PM10 triggers harmful chemicals and inflammation in the eye, which then makes bacterial infections worse. Researchers will also explore if a new antioxidant medication could help reverse these damaging effects.
Who could benefit from this research
Good fit: Patients who experience eye inflammation or infections, particularly those living in areas with high air pollution, could potentially benefit from future treatments developed from this research.
Not a fit: Patients whose eye conditions are not related to air pollution or oxidative stress would likely not receive direct benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments or preventive strategies for eye problems caused by air pollution and related infections.
How similar studies have performed: This work is novel in its mechanistic investigation of how airborne particles affect the eye and increase infection risk.
Where this research is happening
Detroit, United States
- Wayne State University — Detroit, United States (Active)
Researchers
- Principal investigator: Hazlett, Linda D — Wayne State University
- Study coordinator: Hazlett, Linda D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.